Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
ACS Chemical Biology|May 4, 2019
High-Throughput Quantification of Surface Protein Internalization and DegradationJakob C Stüber, Florian Kast, Andreas PlückthunOncoimmunology|February 1, 2021
Advances in identification and selection of personalized neoantigen/T-cell pairs for autologous adoptive T cell therapiesFlorian Kast, Christian Klein, Pablo Umaña, et al.New Biotechnology|March 23, 2015
Optimization of a quantitative PCR based method for plasmid copy number determination in human cell linesLukas Fliedl, Florian Kast, Johannes Grillari, et al.Mabs|March 15, 2018
Modification of the kinetic stability of immunoglobulin G by solvent additivesJonas V Schaefer, Erik Sedlák, Florian Kast, et al.Science Signaling|January 24, 2019
Systemic analysis of tyrosine kinase signaling reveals a common adaptive response program in a HER2-positive breast cancerMartin Schwill, Rastislav Tamaskovic, Aaron S Gajadhar, et al.Protein Science : a Publication of the Protein Society|August 24, 2017
Analysis of IgG kinetic stability by differential scanning calorimetry, probe fluorescence and light scatteringMichal Nemergut, Gabriel Žoldák, Jonas V Schaefer, et al.Journal of Biotechnology|February 21, 2014
Novel human renal proximal tubular cell line for the production of complex proteinsLukas Fliedl, Gabriele Manhart, Florian Kast, et al.Journal of Molecular Biology|April 2, 2019
Inhibition of the MET Kinase Activity and Cell Growth in MET-Addicted Cancer Cells by Bi-Paratopic LinkingFabio Andres, Luisa Iamele, Timo Meyer, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|August 29, 2023
FAP-retargeted Ad5 enables in vivo gene delivery to stromal cells in the tumor microenvironmentK Patricia Hartmann, Merel van Gogh, Patrick C Freitag, et al.Nature Communications|June 19, 2021
Engineering an anti-HER2 biparatopic antibody with a multimodal mechanism of actionFlorian Kast, Martin Schwill, Jakob C Stüber, et al.Pageof 1